LONDON
The FTSE 100 ended a choppy midweek session flat. Meanwhile, Wall Street was higher on the back of a lower-than-expected US CPI for April. In London, caution prevailed after the BOE warned inflation could spike above 4% this year. On the trading floor, miners rallied on speculation of Chinese stake-building in BHP BILLITON (+4.85%) and a positive update from ENRC (+7.19%). On the downside, ALLIANCE & LEICESTER (-2.83%) extended yesterday's losses on fears of further write-downs. More pain for financials as BRADFORD & BINGLEY (-9.29%) unveiled a GBP300m rights issue, at a 48% discount, and said the next dividend will be paid in shares. ASTRAZENECA (+1.87%) gained after the FDA approved the use of Seroquel for maintenance treatment of manic depression. SAINSBURY (-3.91%) reported in-line FY profits but shares fell on outlook. FIRST GROUP (-6.26%) plunged on news it will place up to 43.7m new shares. TESCO (-1.72%) buys 36 stores from South Korea's E-Land for GBP958m. COMPASS (+4.6%) posted solid interim results and said it will buy back GBP400m worth of shares. AMEC (-1.26%) said trading so far is slightly better than expected. BARRATT (-3.4%) reported a relatively encouraging start to the new calendar year but said conditions have been worsening significantly since March. LOGICA (+3.98%) announced a 3% rise in FY revenues. JOHNSTON PRESS (-15.1%) plummeted on a GBP212m rights issue.
PARIS
The CAC 40 (+1.13%) closed the session firmly higher while Wall Street trades in positive territory following a lower-than-expected CPI reading. Back home, a flurry of earnings reports made the waves. BNP PARIBAS (+4.86%) posted a 21% slide in 1Q net profit to EUR 1.981bn - not as bad as generally feared. The bank reiterated it is not planning a move for SOCGEN (+0.59%). DEXIA's (-1.01%) 1Q core earnings topped expectations, coming in at EUR 769m, up from EUR 88m for the same period a year ago. Also among financials, ING downgraded CREDIT AGRICOLE (-0.31%) to hold from buy. Elsewhere, EADS's (+5.85%) 1Q core earnings beat expectations - coming in at EUR 769m, up from EUR 88m for the same period a year ago. ARCELOR MITTAL (+4.13%) reported broadly in-line 1Q numbers, with EBITDA at US$5.0bn and net profit at US$2.4bn. VINCI (+2.81%) posted 1Q revenues of EUR 7.2bn, up 7.5% y/y on a comparable basis (up 17.2% y/y reported), and above consensus of EUR 7.02bn. CARREFOUR (+1.02%) unveiled 1Q08 sales of EUR 23.375bn, up 10.5% ex currency (+6.4% LFL), above consensus. Confirmed FY objectives. In the wider market, THALES (+1.42%) tabled 1Q sales up 5.3% to EUR 2.31bn. Confirmed FY targets. ARKEMA (+9.44%) announced 1Q net profit of EUR 72m, up 64%. CGG VERITAS (-2.87%) reported 1Q group revenue of EUR 585m; op income EUR 123m, -14%. INFOGRAMES (-3.15%) unveiled FY sales of EUR 290.70m, down 4.8%.
FRANKFURT
Xetra-Dax (+0.33%) finished the day with minor gains, as US markets traded firmly in the black amid mild inflation data. It was a busy day for earnings releases. E.ON (+0.52%) reported 1Q adjusted EBIT of EUR 3.3bn, missing estimates, but confirmed its 2008 guidance. DEUTSCHE POST's (+2.26%) 1Q core earnings came in shy of expectations, with EBIT slipping 15% y/y to EUR 851m. It also reiterated previously given guidance. THYSSENKRUPP (+1.79%) posted 2Q PTP of EUR 742m, excluding EUR 42m in one-off costs. This was up from EUR 572m a year ago, but still a touch below expectations. Citing a number of problems, it delayed the start of a new mill in Brazil. K+S (+7.6%) saw its 1Q EBIT come in at EUR 226.3m, better than expected. Q-CELLS' (+8.74%) 1Q core earnings also topped expectations, with EBIT coming in at EUR 58.9m. Posting 1Q net profit of EUR 6.9m and confirming its outlook for 2008, SOLON (+1.64%) said it currently plans no capital injection. STADA's (+3.94) quarterly numbers were lower than expected, but analysts pointed to positive momentum. LANXESS (+9.06%) disclosed a 13% rise in 1Q net profit to EUR 103m. AAREAL (-4.98%) tabled a lower-than-expected 1Q net profit of EUR 13m. In M&A news, the FTD reported that INFINEON (+0.15%) was talking with KKR about a merger with chipmaker NXP. MEDIGENE (+11.
All of the views expressed in this research report accurately reflect the research analyst's personal views regarding any and all of the subject securities or issuers. No part of analyst compensation was, is or will be, directly or indirectly related to the specific recommendations or views expressed in this research report. Standard & Poor's Regulatory Disclosure
Any advice, analysis, or recommendations contained in articles labeled "Insight from Standard & Poor's" reflect the views of Standard & Poor's, which operates separately from and independently of BusinessWeek Online. It is possible that BWOL may from time to time publish information that is not consistent with advice, analysis, or recommendations that are published by Standard & Poor's. Standard & Poor's and BusinessWeek Online are each units of The McGraw-Hill Companies, Inc.